Multi-stage mechanisms of tumor metastasis and therapeutic strategies
2024 · Signal Transduction and Targeted Therapy · 125 citations
https://doi.org/10.1038/s41392-024-01955-5
A
Anning Zuo
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
32
Papers
501
Citations
11
h-index
13
i10-index
Anning Zuo is an academic researcher from First Affiliated Hospital of Zhengzhou University. The author has contributed to research in topics: Immune cells in cancer & Cancer Cells and Metastasis & Cancer Immunotherapy and Biomarkers. The author has an h-index of 11, co-authored 28 publications.
ORCID: 0009-0006-6779-8282Papers by this author
worksTHBS2 + cancer-associated fibroblasts promote EMT leading to oxaliplatin resistance via COL8A1-mediated PI3K/AKT activation in colorectal cancer
2024 · Molecular Cancer · 59 citations
https://doi.org/10.1186/s12943-024-02180-y
Infiltrating treg reprogramming in the tumor immune microenvironment and its optimization for immunotherapy
2024 · Biomarker Research · 30 citations
https://doi.org/10.1186/s40364-024-00630-9
THBS2-producing matrix CAFs promote colorectal cancer progression and link to poor prognosis via the CD47-MAPK axis
2025 · Cell Reports · 17 citations
https://doi.org/10.1016/j.celrep.2025.115555
Efferocytosis: The Janus‐Faced Gatekeeper of Aging and Tumor Fate
2025 · Aging Cell · 13 citations
https://doi.org/10.1111/acel.14467
Interactions between microbiota and innate immunity in tumor microenvironment: Novel insights into cancer progression and immunotherapy
2025 · hLife · 9 citations
https://doi.org/10.1016/j.hlife.2025.05.008
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat